What is CorMedix Inc. worth?
With the base-case assumptions below, a discounted cash flow model on CorMedix Inc.'s reported free cash flow gives $74,281.78 per share. The share price was $7.85 on September 25, 2026, 100% below that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 10.0% | 10.0% | $46,387.84 | +590,828% |
| Base | 15.0% | 9.0% | $74,281.78 | +946,165% |
| Bull | 20.0% | 8.0% | $126,221.32 | +1,607,815% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $95,400.72 | $101,985.71 | $110,034.02 | $120,094.42 | $133,029.21 |
| 8.0% | $79,535.95 | $83,806.30 | $88,853.07 | $94,909.20 | $102,311.13 |
| 9.0% | $67,993.11 | $70,912.85 | $74,281.78 | $78,212.19 | $82,857.23 |
| 10.0% | $59,240.56 | $61,316.90 | $63,670.09 | $66,359.44 | $69,462.54 |
| 11.0% | $52,392.07 | $53,914.26 | $55,615.53 | $57,529.46 | $59,698.58 |
Where the presets come from
Base: years 1 to 5 grow at CorMedix Inc.'s revenue growth rate over the last 6 fiscal years (221.3% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions